NTLA - Intellia Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.29
DETAILS
HIGH:
$49.00
LOW:
$13.00
MEDIAN:
$25.00
CONSENSUS:
$26.29
UPSIDE:
108.65%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-03-01 | Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 61,280 | -- | -- |
| 2026-03-01 | Dube Michael P | officer: VP, Chief Accounting Officer | A-Award | 17,250 | -- | -- |
| 2026-03-02 | BASTA JAMES | officer: EVP, General Counsel | SELL | 1,211 | $13.78 | $17K |
| 2026-03-01 | BASTA JAMES | officer: EVP, General Counsel | A-Award | 65,829 | $13.78 | $907K |
| 2026-03-01 | Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 9,943 | -- | -- |
| 2026-03-01 | Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 14,204 | $13.78 | $196K |
| 2026-03-01 | Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 87,543 | $13.78 | $1.2M |
| 2026-03-01 | Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 39,200 | -- | -- |
| 2026-03-01 | Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 56,000 | $13.78 | $772K |
| 2026-03-01 | Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 7,353 | -- | -- |
| 2026-03-01 | Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 10,505 | $13.78 | $145K |
| 2026-03-02 | Clark Eliana | officer: EVP, Chief Technical Officer | SELL | 607 | $13.78 | $8K |
| 2026-03-01 | LEONARD JOHN M | director, officer: President and CEO | A-Award | 156,400 | -- | -- |
| 2026-03-01 | LEONARD JOHN M | director, officer: President and CEO | A-Award | 225,400 | $13.78 | $3.1M |
| 2026-03-01 | BASTA JAMES | officer: EVP, General Counsel | A-Award | 46,080 | -- | -- |
| 2026-01-05 | Clark Eliana | officer: EVP, Chief Technical Officer | SELL | 9,515 | $9.21 | $88K |
| 2026-01-05 | LEONARD JOHN M | director, officer: President and CEO | SELL | 34,146 | $9.21 | $314K |
| 2026-01-05 | BASTA JAMES | officer: EVP, General Counsel | SELL | 10,397 | $9.21 | $96K |
| 2026-01-05 | Cohen Fred E | director | BUY | 150,000 | $9.35 | $1.4M |
| 2026-01-05 | Lebwohl David | officer: EVP, Chief Medical Officer | SELL | 11,903 | $9.21 | $110K |
| 2026-01-05 | Dube Michael P | officer: VP, Chief Accounting Officer | SELL | 2,989 | $9.21 | $28K |
| 2026-01-05 | Schultes Birgit C | officer: EVP, Chief Scientific Officer | SELL | 8,508 | $9.21 | $78K |
| 2026-01-05 | Dulac Edward J III | officer: EVP, Chief Financial Officer | SELL | 6,379 | $9.21 | $59K |
| 2025-12-11 | LEONARD JOHN M | director, officer: President and CEO | SELL | 49,959 | $9.49 | $474K |
| 2025-12-11 | LEONARD JOHN M | director, officer: President and CEO | SELL | 32,832 | $9.47 | $311K |